Doccla Secures £35M in Series B Funding Round
Doccla Secures £35M in Series B Funding for European Expansion
Doccla, a virtual ward and remote patient monitoring services provider, has successfully secured £35 million in a Series B funding round. The investment was led by Lakestar, with additional contributions from Elaia and previous investors such as General Catalyst, Bertelsmann Investments, and Speedinvest. Notably, Oliver Heimes from Lakestar is poised to join Doccla's board.
The secured funds will be deployed to bolster Doccla's presence in the UK and Ireland. The company has established collaborations with NHS Trusts across various regions in the UK and has also partnered with Ireland’s Health Service Executive. Furthermore, Doccla is strategizing to extend its footprint across Europe, with a specific focus on France and the DACH region while also considering potential ventures into international markets outside Europe.
Operating under the regulations of the Care Quality Commission in England, Doccla offers 24/7 monitoring across 40 medical pathways. This technology empowers healthcare staff to monitor patient data in real-time, thereby preventing the escalation of issues and reducing emergency admissions.
Founder Martin Ratz emphasizes the company's mission of providing hospital-level care at home, benefiting both patients and healthcare providers by optimizing resources. Heimes expressed confidence in Doccla's ability to maintain its market leadership in the UK while successfully expanding into new markets.
It's worth noting that Doccla was established by Martin Ratz and Dag Larsson following Ratz's personal encounter with a heart attack, which illuminated a gap in post-inpatient care. The company is committed to further investment in data science operations, with a particular focus on the Life Sciences sector.
Key Takeaways
- Doccla raises £35M in Series B funding led by Lakestar.
- Funding to expand services across Europe, focusing on France and the DACH region.
- Doccla aims to reduce emergency admissions and alleviate patient stress through 24/7 monitoring.
- Company plans to scale European operations and explore Life Sciences sector.
- Doccla's technology enables real-time patient data access for medical staff, improving care quality.
Analysis
The £35 million Series B funding secured by Doccla, spearheaded by Lakestar, marks a pivotal acceleration of its expansion across Europe, especially in France and the DACH region. This substantial influx of capital fortifies Doccla's capacity to provide remote patient monitoring, thus enhancing healthcare efficiency and patient care quality. The expansion endeavors to disrupt traditional healthcare models, potentially resulting in reduced hospital admissions and easing resource constraints for healthcare providers. Doccla's sustained focus on data science in the Life Sciences sector holds the potential to pioneer innovative healthcare solutions, exerting a profound influence on global healthcare delivery and technology investments.
Did You Know?
- Virtual Ward and Remote Patient Monitoring Services:
- Virtual wards involve the remote delivery of healthcare services, often in the patient's home, utilizing technology to monitor and manage their health conditions. This approach enables patients to receive hospital-level care without physically being present in a hospital.
- DACH Region:
- The DACH region, an economic term encompassing Germany (Deutschland), Austria (Österreich), and Switzerland (Schweiz or Confoederatio Helvetica in Latin), is commonly used in business and finance to denote the combined market of these three countries. Sharing a common language (German) and similar cultural and economic characteristics, these nations form a cohesive economic union.
- Life Sciences Sector:
- The Life Sciences sector encompasses diverse fields and industries related to the study of living organisms and their applications, including biotechnology, pharmaceuticals, biomedical technologies, and agriculture. In the context of Doccla's plans, investing in this sector likely involves leveraging data science to enhance healthcare outcomes and operational efficiencies.